| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peroxiredoxins | 55 | 2022 | 117 | 7.820 |
Why?
|
| Cysteine | 49 | 2022 | 145 | 6.690 |
Why?
|
| Proteins | 20 | 2020 | 149 | 4.280 |
Why?
|
| Sulfenic Acids | 23 | 2019 | 57 | 3.830 |
Why?
|
| Oxidation-Reduction | 68 | 2022 | 274 | 3.670 |
Why?
|
| Peroxidases | 20 | 2017 | 36 | 3.170 |
Why?
|
| Hydrogen Peroxide | 31 | 2022 | 85 | 3.080 |
Why?
|
| Salmonella typhimurium | 17 | 2018 | 34 | 2.250 |
Why?
|
| Bacterial Proteins | 13 | 2021 | 93 | 1.960 |
Why?
|
| Signal Transduction | 24 | 2022 | 727 | 1.950 |
Why?
|
| Sulfhydryl Compounds | 13 | 2022 | 35 | 1.830 |
Why?
|
| Protein Processing, Post-Translational | 13 | 2022 | 78 | 1.810 |
Why?
|
| Catalysis | 22 | 2021 | 71 | 1.440 |
Why?
|
| Oxidative Stress | 11 | 2023 | 255 | 1.430 |
Why?
|
| Disulfides | 16 | 2019 | 43 | 1.330 |
Why?
|
| Thioredoxins | 9 | 2016 | 21 | 1.310 |
Why?
|
| Escherichia coli | 9 | 2016 | 88 | 1.210 |
Why?
|
| Escherichia coli Proteins | 11 | 2014 | 34 | 1.170 |
Why?
|
| Thioredoxin-Disulfide Reductase | 7 | 2016 | 11 | 1.130 |
Why?
|
| Models, Molecular | 32 | 2021 | 204 | 1.120 |
Why?
|
| Kinetics | 16 | 2022 | 250 | 1.060 |
Why?
|
| Peroxides | 12 | 2019 | 32 | 1.060 |
Why?
|
| Amino Acid Sequence | 28 | 2018 | 290 | 1.000 |
Why?
|
| Electrons | 2 | 2015 | 12 | 0.880 |
Why?
|
| Free Radicals | 2 | 2015 | 10 | 0.880 |
Why?
|
| Computational Biology | 2 | 2022 | 99 | 0.830 |
Why?
|
| Reactive Oxygen Species | 11 | 2023 | 163 | 0.790 |
Why?
|
| Molecular Sequence Data | 23 | 2017 | 359 | 0.780 |
Why?
|
| Lipopolysaccharides | 1 | 2023 | 121 | 0.770 |
Why?
|
| Mass Spectrometry | 9 | 2017 | 98 | 0.750 |
Why?
|
| Cyclohexanones | 7 | 2016 | 20 | 0.740 |
Why?
|
| Oxidoreductases | 5 | 2015 | 25 | 0.720 |
Why?
|
| Animals | 34 | 2022 | 8199 | 0.700 |
Why?
|
| Protein Conformation | 16 | 2015 | 110 | 0.670 |
Why?
|
| Fluorescent Dyes | 5 | 2020 | 52 | 0.610 |
Why?
|
| Catalytic Domain | 18 | 2021 | 68 | 0.610 |
Why?
|
| Antioxidants | 5 | 2010 | 122 | 0.610 |
Why?
|
| Substrate Specificity | 11 | 2016 | 80 | 0.600 |
Why?
|
| Protein Folding | 9 | 2021 | 31 | 0.590 |
Why?
|
| Crystallography, X-Ray | 18 | 2021 | 87 | 0.590 |
Why?
|
| Mitochondria | 8 | 2019 | 211 | 0.570 |
Why?
|
| Molecular Probes | 4 | 2020 | 13 | 0.570 |
Why?
|
| Staining and Labeling | 5 | 2018 | 62 | 0.560 |
Why?
|
| Humans | 53 | 2023 | 32274 | 0.560 |
Why?
|
| Glutathione | 4 | 2015 | 54 | 0.560 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2017 | 33 | 0.550 |
Why?
|
| Epithelial Cells | 2 | 2017 | 132 | 0.520 |
Why?
|
| Fibroblasts | 1 | 2017 | 119 | 0.510 |
Why?
|
| Chondrocytes | 4 | 2019 | 70 | 0.500 |
Why?
|
| Xanthomonas campestris | 4 | 2021 | 7 | 0.480 |
Why?
|
| Homeodomain Proteins | 4 | 2019 | 53 | 0.480 |
Why?
|
| Vitis | 1 | 2016 | 13 | 0.470 |
Why?
|
| Binding Sites | 12 | 2017 | 144 | 0.440 |
Why?
|
| Sequence Homology, Amino Acid | 9 | 2017 | 74 | 0.410 |
Why?
|
| Schizosaccharomyces pombe Proteins | 2 | 2012 | 4 | 0.390 |
Why?
|
| Biocatalysis | 5 | 2015 | 19 | 0.380 |
Why?
|
| Iodoacetamide | 3 | 2013 | 7 | 0.370 |
Why?
|
| Schizosaccharomyces | 1 | 2012 | 5 | 0.360 |
Why?
|
| Mutagenesis, Site-Directed | 5 | 2011 | 63 | 0.360 |
Why?
|
| Databases, Protein | 4 | 2017 | 13 | 0.350 |
Why?
|
| Dimerization | 9 | 2012 | 30 | 0.340 |
Why?
|
| Thermodynamics | 4 | 2015 | 57 | 0.330 |
Why?
|
| Enzymes | 1 | 2010 | 6 | 0.330 |
Why?
|
| Protein Engineering | 1 | 2010 | 19 | 0.320 |
Why?
|
| Bacteria | 2 | 2010 | 54 | 0.320 |
Why?
|
| Treponema pallidum | 1 | 2010 | 7 | 0.320 |
Why?
|
| Point Mutation | 2 | 2008 | 29 | 0.320 |
Why?
|
| Protein Structure, Tertiary | 10 | 2014 | 112 | 0.310 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 2018 | 69 | 0.310 |
Why?
|
| Biosensing Techniques | 1 | 2010 | 24 | 0.310 |
Why?
|
| Mutation | 9 | 2022 | 497 | 0.300 |
Why?
|
| Mice | 14 | 2022 | 2571 | 0.300 |
Why?
|
| Flavoproteins | 3 | 2005 | 6 | 0.280 |
Why?
|
| Sequence Alignment | 7 | 2016 | 58 | 0.270 |
Why?
|
| Mutagenesis, Insertional | 1 | 2008 | 17 | 0.270 |
Why?
|
| Periplasmic Proteins | 2 | 2009 | 3 | 0.270 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2007 | 20 | 0.270 |
Why?
|
| Neovascularization, Physiologic | 3 | 2022 | 114 | 0.270 |
Why?
|
| Superoxide Dismutase | 2 | 2022 | 41 | 0.260 |
Why?
|
| Cell Line, Tumor | 7 | 2022 | 729 | 0.260 |
Why?
|
| Peroxynitrous Acid | 3 | 2019 | 6 | 0.260 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2015 | 99 | 0.260 |
Why?
|
| Models, Biological | 6 | 2017 | 408 | 0.260 |
Why?
|
| Sequence Analysis, Protein | 2 | 2017 | 4 | 0.250 |
Why?
|
| Spectrophotometry | 7 | 2008 | 22 | 0.250 |
Why?
|
| Cartilage, Articular | 2 | 2019 | 72 | 0.250 |
Why?
|
| Clostridium | 2 | 2005 | 3 | 0.240 |
Why?
|
| Peptide Fragments | 4 | 2016 | 414 | 0.230 |
Why?
|
| Osteoarthritis | 2 | 2016 | 73 | 0.220 |
Why?
|
| Cell Line | 5 | 2022 | 454 | 0.220 |
Why?
|
| Protein Binding | 5 | 2019 | 244 | 0.220 |
Why?
|
| Iron | 2 | 2022 | 94 | 0.220 |
Why?
|
| Oxidants | 1 | 2005 | 15 | 0.220 |
Why?
|
| Electron Transport | 4 | 2010 | 16 | 0.220 |
Why?
|
| Transaminases | 4 | 2008 | 10 | 0.220 |
Why?
|
| Enzyme Activation | 7 | 2017 | 138 | 0.210 |
Why?
|
| Entamoeba histolytica | 2 | 2016 | 4 | 0.210 |
Why?
|
| Methionine | 1 | 2004 | 7 | 0.210 |
Why?
|
| Cytokines | 2 | 2023 | 237 | 0.210 |
Why?
|
| Indicators and Reagents | 2 | 2018 | 14 | 0.210 |
Why?
|
| Cloning, Molecular | 4 | 2016 | 74 | 0.210 |
Why?
|
| Cell Nucleus | 2 | 2022 | 111 | 0.210 |
Why?
|
| Molecular Structure | 5 | 2019 | 58 | 0.210 |
Why?
|
| Dihydrolipoyllysine-Residue Acetyltransferase | 1 | 2023 | 1 | 0.200 |
Why?
|
| Pyruvates | 1 | 2023 | 2 | 0.200 |
Why?
|
| Protozoan Proteins | 2 | 2016 | 9 | 0.200 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2022 | 24 | 0.200 |
Why?
|
| NIH 3T3 Cells | 4 | 2017 | 41 | 0.200 |
Why?
|
| Durapatite | 1 | 2003 | 9 | 0.190 |
Why?
|
| Phosphates | 1 | 2003 | 26 | 0.190 |
Why?
|
| Models, Chemical | 6 | 2012 | 35 | 0.190 |
Why?
|
| Phylogeny | 4 | 2016 | 67 | 0.190 |
Why?
|
| Histone Demethylases | 1 | 2022 | 8 | 0.190 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 16 | 0.180 |
Why?
|
| Lysophospholipids | 2 | 2014 | 26 | 0.180 |
Why?
|
| Prodrugs | 1 | 2022 | 17 | 0.180 |
Why?
|
| Lymphocyte Activation | 3 | 2015 | 94 | 0.180 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2020 | 42 | 0.180 |
Why?
|
| Copper | 1 | 2022 | 11 | 0.180 |
Why?
|
| Dithionitrobenzoic Acid | 5 | 2008 | 5 | 0.180 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2015 | 58 | 0.180 |
Why?
|
| Protein Structure, Secondary | 6 | 2016 | 59 | 0.180 |
Why?
|
| Tyrosine | 2 | 2019 | 24 | 0.180 |
Why?
|
| Carrier Proteins | 2 | 2018 | 144 | 0.180 |
Why?
|
| Neoplastic Stem Cells | 1 | 2022 | 96 | 0.180 |
Why?
|
| Amino Acids | 1 | 2022 | 52 | 0.170 |
Why?
|
| Phosphorylation | 5 | 2019 | 250 | 0.170 |
Why?
|
| Cell Proliferation | 7 | 2017 | 603 | 0.170 |
Why?
|
| Helicobacter pylori | 1 | 2001 | 8 | 0.170 |
Why?
|
| Amino Acid Motifs | 6 | 2021 | 25 | 0.170 |
Why?
|
| Protein Structure, Quaternary | 3 | 2011 | 22 | 0.170 |
Why?
|
| Cells, Cultured | 6 | 2019 | 839 | 0.170 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2000 | 10 | 0.170 |
Why?
|
| Cell Cycle | 3 | 2017 | 75 | 0.160 |
Why?
|
| Tandem Repeat Sequences | 1 | 2000 | 7 | 0.160 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 3 | 2013 | 34 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2016 | 74 | 0.160 |
Why?
|
| Inflammation | 1 | 2023 | 506 | 0.160 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2000 | 120 | 0.160 |
Why?
|
| Recombinant Proteins | 5 | 2016 | 264 | 0.160 |
Why?
|
| Sulfinic Acids | 3 | 2016 | 14 | 0.150 |
Why?
|
| Protein Subunits | 2 | 2010 | 40 | 0.150 |
Why?
|
| Molecular Chaperones | 1 | 2019 | 13 | 0.150 |
Why?
|
| Organophosphorus Compounds | 1 | 2019 | 30 | 0.150 |
Why?
|
| Vinculin | 1 | 2018 | 1 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2019 | 41 | 0.140 |
Why?
|
| Auranofin | 2 | 2016 | 4 | 0.140 |
Why?
|
| Integrins | 1 | 2018 | 17 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2018 | 5 | 0.140 |
Why?
|
| Cell Adhesion | 1 | 2018 | 100 | 0.140 |
Why?
|
| Ultracentrifugation | 3 | 2011 | 8 | 0.140 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2018 | 55 | 0.140 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 74 | 0.140 |
Why?
|
| Cytological Techniques | 1 | 2018 | 17 | 0.140 |
Why?
|
| NADP | 2 | 2013 | 12 | 0.140 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 762 | 0.140 |
Why?
|
| User-Computer Interface | 2 | 2016 | 54 | 0.140 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2018 | 90 | 0.140 |
Why?
|
| Cell Movement | 3 | 2018 | 167 | 0.130 |
Why?
|
| Mitochondrial Proteins | 1 | 2018 | 72 | 0.130 |
Why?
|
| Phenols | 1 | 2017 | 18 | 0.130 |
Why?
|
| Sirtuins | 1 | 2017 | 21 | 0.130 |
Why?
|
| Sulfones | 1 | 2017 | 23 | 0.130 |
Why?
|
| MAP Kinase Signaling System | 1 | 2017 | 65 | 0.130 |
Why?
|
| Tetrazoles | 1 | 2017 | 61 | 0.130 |
Why?
|
| Drug Discovery | 1 | 2017 | 38 | 0.130 |
Why?
|
| Protein Interaction Mapping | 1 | 2017 | 11 | 0.130 |
Why?
|
| Mutagenesis | 2 | 2011 | 34 | 0.130 |
Why?
|
| Homeostasis | 1 | 2017 | 130 | 0.130 |
Why?
|
| High-Throughput Screening Assays | 2 | 2017 | 13 | 0.120 |
Why?
|
| Glucose | 1 | 2017 | 160 | 0.120 |
Why?
|
| Transcription, Genetic | 2 | 2010 | 140 | 0.120 |
Why?
|
| Titrimetry | 3 | 2007 | 4 | 0.120 |
Why?
|
| Dithiothreitol | 2 | 2013 | 8 | 0.120 |
Why?
|
| Monocytes | 1 | 2017 | 141 | 0.120 |
Why?
|
| Cell Membrane | 2 | 2017 | 109 | 0.120 |
Why?
|
| Antiprotozoal Agents | 1 | 2016 | 3 | 0.120 |
Why?
|
| Plant Proteins | 1 | 2016 | 14 | 0.120 |
Why?
|
| src-Family Kinases | 1 | 2016 | 15 | 0.120 |
Why?
|
| Nitro Compounds | 1 | 2015 | 3 | 0.120 |
Why?
|
| Amino Acid Substitution | 3 | 2013 | 40 | 0.120 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2015 | 24 | 0.120 |
Why?
|
| Organogold Compounds | 1 | 2015 | 4 | 0.120 |
Why?
|
| Bilirubin | 1 | 2015 | 23 | 0.110 |
Why?
|
| Gene Expression Regulation | 2 | 2017 | 478 | 0.110 |
Why?
|
| Glutaredoxins | 2 | 2008 | 9 | 0.110 |
Why?
|
| Hematologic Neoplasms | 1 | 2015 | 39 | 0.110 |
Why?
|
| Mutant Proteins | 2 | 2012 | 15 | 0.110 |
Why?
|
| Anthracyclines | 1 | 2015 | 52 | 0.110 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2007 | 32 | 0.110 |
Why?
|
| Immunologic Memory | 2 | 2012 | 33 | 0.110 |
Why?
|
| Evolution, Molecular | 3 | 2011 | 41 | 0.110 |
Why?
|
| Cycloparaffins | 1 | 2014 | 2 | 0.110 |
Why?
|
| Nitrogen | 1 | 2014 | 10 | 0.110 |
Why?
|
| Base Sequence | 3 | 2011 | 252 | 0.110 |
Why?
|
| Erythrocytes | 1 | 2014 | 41 | 0.100 |
Why?
|
| Sulfur Compounds | 2 | 2012 | 7 | 0.100 |
Why?
|
| Isoenzymes | 2 | 2014 | 67 | 0.100 |
Why?
|
| Streptococcus mutans | 2 | 2005 | 5 | 0.100 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2013 | 6 | 0.100 |
Why?
|
| Bordetella pertussis | 1 | 2013 | 7 | 0.100 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2013 | 14 | 0.100 |
Why?
|
| Protein Stability | 2 | 2014 | 27 | 0.100 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2013 | 40 | 0.100 |
Why?
|
| Structure-Activity Relationship | 2 | 2013 | 87 | 0.100 |
Why?
|
| Molecular Weight | 3 | 2002 | 55 | 0.100 |
Why?
|
| Benzene Derivatives | 1 | 2013 | 3 | 0.100 |
Why?
|
| Enzyme Assays | 1 | 2013 | 5 | 0.100 |
Why?
|
| Genetic Loci | 1 | 2013 | 143 | 0.100 |
Why?
|
| Endothelial Cells | 2 | 2011 | 193 | 0.100 |
Why?
|
| Neutrophils | 1 | 2013 | 120 | 0.100 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2012 | 8 | 0.090 |
Why?
|
| Nitroglycerin | 1 | 2012 | 10 | 0.090 |
Why?
|
| Chlamydia | 1 | 2012 | 2 | 0.090 |
Why?
|
| Periplasm | 1 | 2012 | 2 | 0.090 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2012 | 8 | 0.090 |
Why?
|
| Protein Denaturation | 2 | 2009 | 16 | 0.090 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 116 | 0.090 |
Why?
|
| Blood Vessels | 1 | 2012 | 57 | 0.090 |
Why?
|
| Parasites | 1 | 2012 | 1 | 0.090 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2012 | 70 | 0.090 |
Why?
|
| Stroke Volume | 1 | 2015 | 417 | 0.090 |
Why?
|
| B-Lymphocytes | 1 | 2012 | 79 | 0.090 |
Why?
|
| Genes, Bacterial | 2 | 2002 | 9 | 0.090 |
Why?
|
| NAD | 2 | 2002 | 27 | 0.090 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2011 | 16 | 0.090 |
Why?
|
| Cyclopentanes | 1 | 2011 | 17 | 0.090 |
Why?
|
| Protein Isoforms | 1 | 2011 | 60 | 0.090 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2011 | 40 | 0.080 |
Why?
|
| Time Factors | 2 | 2008 | 2204 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 113 | 0.080 |
Why?
|
| Hydrogen Bonding | 3 | 2021 | 18 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 595 | 0.080 |
Why?
|
| Eukaryota | 1 | 2010 | 4 | 0.080 |
Why?
|
| Phosphines | 1 | 2010 | 3 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2010 | 13 | 0.080 |
Why?
|
| S-Nitrosoglutathione | 1 | 2010 | 5 | 0.080 |
Why?
|
| Caveolae | 1 | 2010 | 4 | 0.080 |
Why?
|
| S-Nitrosothiols | 1 | 2010 | 5 | 0.080 |
Why?
|
| Genome, Bacterial | 1 | 2010 | 6 | 0.080 |
Why?
|
| Peroxidase | 2 | 2019 | 27 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 3 | 2022 | 792 | 0.080 |
Why?
|
| Biotinylation | 1 | 2010 | 12 | 0.080 |
Why?
|
| Ovarian Neoplasms | 1 | 2010 | 84 | 0.080 |
Why?
|
| Rabbits | 1 | 2010 | 219 | 0.080 |
Why?
|
| Aging | 1 | 2016 | 942 | 0.080 |
Why?
|
| Oxygen | 3 | 2010 | 138 | 0.080 |
Why?
|
| Ischemia | 1 | 2010 | 115 | 0.070 |
Why?
|
| Incubators | 1 | 2008 | 3 | 0.070 |
Why?
|
| Horseradish Peroxidase | 1 | 2008 | 7 | 0.070 |
Why?
|
| Buffers | 1 | 2008 | 12 | 0.070 |
Why?
|
| Alkylation | 1 | 2008 | 7 | 0.070 |
Why?
|
| Absorption | 1 | 2008 | 16 | 0.070 |
Why?
|
| Circular Dichroism | 2 | 2017 | 39 | 0.070 |
Why?
|
| Binding, Competitive | 1 | 2008 | 43 | 0.070 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2008 | 20 | 0.070 |
Why?
|
| Doxorubicin | 2 | 2022 | 76 | 0.070 |
Why?
|
| Protein Multimerization | 3 | 2017 | 25 | 0.070 |
Why?
|
| Radiation Tolerance | 1 | 2008 | 27 | 0.070 |
Why?
|
| Crystallization | 2 | 2005 | 18 | 0.070 |
Why?
|
| Molecular Biology | 1 | 2008 | 8 | 0.070 |
Why?
|
| Trinucleotide Repeats | 1 | 2008 | 9 | 0.070 |
Why?
|
| Isotopes | 1 | 2007 | 10 | 0.070 |
Why?
|
| Deuterium | 1 | 2007 | 11 | 0.070 |
Why?
|
| Rhodamines | 1 | 2007 | 6 | 0.070 |
Why?
|
| Biotin | 1 | 2007 | 7 | 0.070 |
Why?
|
| Cyclohexenes | 1 | 2007 | 17 | 0.070 |
Why?
|
| Acetanilides | 1 | 2007 | 12 | 0.070 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2007 | 40 | 0.070 |
Why?
|
| Molecular Dynamics Simulation | 3 | 2012 | 16 | 0.070 |
Why?
|
| Vitamin K 3 | 2 | 2019 | 7 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 717 | 0.070 |
Why?
|
| Fibronectins | 2 | 2018 | 39 | 0.060 |
Why?
|
| Glioma | 1 | 2008 | 137 | 0.060 |
Why?
|
| Static Electricity | 3 | 2012 | 13 | 0.060 |
Why?
|
| Peptides | 1 | 2007 | 127 | 0.060 |
Why?
|
| Actins | 3 | 2012 | 54 | 0.060 |
Why?
|
| Nitrates | 2 | 2019 | 29 | 0.060 |
Why?
|
| Repressor Proteins | 1 | 2006 | 50 | 0.060 |
Why?
|
| Threonine | 1 | 2005 | 11 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2006 | 183 | 0.050 |
Why?
|
| Female | 6 | 2022 | 19942 | 0.050 |
Why?
|
| Glutathione Reductase | 1 | 2004 | 9 | 0.050 |
Why?
|
| Microscopy, Confocal | 2 | 2016 | 74 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 257 | 0.050 |
Why?
|
| Chromatography | 1 | 2003 | 4 | 0.050 |
Why?
|
| Lipoxygenase Inhibitors | 1 | 2003 | 2 | 0.050 |
Why?
|
| Leukotrienes | 1 | 2003 | 3 | 0.050 |
Why?
|
| Trypsin | 1 | 2003 | 10 | 0.050 |
Why?
|
| Lipid Peroxides | 1 | 2003 | 7 | 0.050 |
Why?
|
| Fluoresceins | 1 | 2003 | 9 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2003 | 83 | 0.050 |
Why?
|
| Ultraviolet Rays | 1 | 2003 | 48 | 0.050 |
Why?
|
| Receptors, Lysophosphatidic Acid | 2 | 2014 | 6 | 0.050 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2002 | 19 | 0.050 |
Why?
|
| Hydroxyl Radical | 1 | 2002 | 3 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2003 | 108 | 0.050 |
Why?
|
| 4-Chloro-7-nitrobenzofurazan | 1 | 2002 | 1 | 0.050 |
Why?
|
| Enzyme Stability | 1 | 2002 | 6 | 0.050 |
Why?
|
| DNA, Bacterial | 1 | 2002 | 28 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2015 | 183 | 0.040 |
Why?
|
| Neurotransmitter Agents | 1 | 2002 | 35 | 0.040 |
Why?
|
| Cattle | 1 | 2022 | 116 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2021 | 93 | 0.040 |
Why?
|
| Flavins | 1 | 2001 | 6 | 0.040 |
Why?
|
| Flavin-Adenine Dinucleotide | 1 | 2001 | 6 | 0.040 |
Why?
|
| Genes, Essential | 1 | 2001 | 4 | 0.040 |
Why?
|
| Helicobacter Infections | 1 | 2001 | 9 | 0.040 |
Why?
|
| Plasmids | 1 | 2001 | 50 | 0.040 |
Why?
|
| Oxidoreductases Acting on Sulfur Group Donors | 2 | 2014 | 12 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2001 | 132 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 2 | 2012 | 8 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 2 | 2012 | 9 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2022 | 454 | 0.040 |
Why?
|
| Rats | 2 | 2018 | 1895 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2012 | 299 | 0.040 |
Why?
|
| Leishmania infantum | 1 | 2019 | 1 | 0.040 |
Why?
|
| Cryoelectron Microscopy | 1 | 2019 | 3 | 0.040 |
Why?
|
| Male | 4 | 2022 | 19437 | 0.040 |
Why?
|
| Antifibrinolytic Agents | 1 | 2019 | 14 | 0.040 |
Why?
|
| Adult | 3 | 2016 | 9256 | 0.040 |
Why?
|
| Insulin | 1 | 2000 | 359 | 0.040 |
Why?
|
| Fluorescence | 1 | 2018 | 22 | 0.030 |
Why?
|
| ROC Curve | 1 | 2018 | 169 | 0.030 |
Why?
|
| Middle Aged | 3 | 2016 | 11848 | 0.030 |
Why?
|
| Sulfhydryl Reagents | 1 | 2017 | 6 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2017 | 69 | 0.030 |
Why?
|
| Nucleotides | 1 | 2017 | 17 | 0.030 |
Why?
|
| Database Management Systems | 1 | 2017 | 11 | 0.030 |
Why?
|
| Multigene Family | 1 | 2017 | 50 | 0.030 |
Why?
|
| Catalase | 1 | 2016 | 15 | 0.030 |
Why?
|
| History, Ancient | 1 | 2016 | 4 | 0.030 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2016 | 10 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2016 | 54 | 0.030 |
Why?
|
| Transgenes | 1 | 2016 | 46 | 0.030 |
Why?
|
| Antirheumatic Agents | 1 | 2016 | 28 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2016 | 42 | 0.030 |
Why?
|
| Cartilage | 1 | 2016 | 33 | 0.030 |
Why?
|
| Idarubicin | 1 | 2015 | 8 | 0.030 |
Why?
|
| Daunorubicin | 1 | 2015 | 27 | 0.030 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2015 | 19 | 0.030 |
Why?
|
| Acridines | 1 | 2015 | 18 | 0.030 |
Why?
|
| Urea | 1 | 2015 | 38 | 0.030 |
Why?
|
| Platinum | 1 | 2015 | 20 | 0.030 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2015 | 22 | 0.030 |
Why?
|
| Viral Load | 1 | 2015 | 73 | 0.030 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2015 | 69 | 0.030 |
Why?
|
| Gene Expression | 1 | 2016 | 345 | 0.030 |
Why?
|
| Echinococcus granulosus | 1 | 2014 | 2 | 0.030 |
Why?
|
| Phenylpropionates | 1 | 2014 | 3 | 0.030 |
Why?
|
| Endosomes | 1 | 2014 | 13 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2014 | 19 | 0.030 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2015 | 168 | 0.030 |
Why?
|
| Vesicular Transport Proteins | 1 | 2014 | 12 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2014 | 174 | 0.030 |
Why?
|
| Protein Transport | 1 | 2014 | 80 | 0.030 |
Why?
|
| Serine | 1 | 2013 | 11 | 0.030 |
Why?
|
| Methyl Methanesulfonate | 1 | 2013 | 4 | 0.030 |
Why?
|
| Benzamides | 1 | 2014 | 60 | 0.030 |
Why?
|
| Ethylmaleimide | 1 | 2013 | 6 | 0.030 |
Why?
|
| Endopeptidase K | 1 | 2013 | 2 | 0.030 |
Why?
|
| Ascorbic Acid | 1 | 2013 | 21 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2016 | 854 | 0.030 |
Why?
|
| Calcium | 1 | 2015 | 339 | 0.020 |
Why?
|
| Aged | 2 | 2016 | 10260 | 0.020 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2012 | 12 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2012 | 26 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2012 | 36 | 0.020 |
Why?
|
| Biological Transport | 1 | 2012 | 75 | 0.020 |
Why?
|
| Cricetinae | 1 | 2012 | 51 | 0.020 |
Why?
|
| Cell Division | 1 | 2012 | 92 | 0.020 |
Why?
|
| Caulobacter crescentus | 1 | 2012 | 2 | 0.020 |
Why?
|
| Esters | 1 | 2012 | 9 | 0.020 |
Why?
|
| Ketones | 1 | 2012 | 10 | 0.020 |
Why?
|
| Isoflavones | 1 | 2012 | 103 | 0.020 |
Why?
|
| Streptococcus pneumoniae | 1 | 2012 | 38 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2012 | 120 | 0.020 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2011 | 3 | 0.020 |
Why?
|
| Phospholipase C gamma | 1 | 2011 | 6 | 0.020 |
Why?
|
| DNA Primers | 1 | 2011 | 84 | 0.020 |
Why?
|
| Cell Survival | 1 | 2012 | 288 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 112 | 0.020 |
Why?
|
| Entropy | 1 | 2010 | 11 | 0.020 |
Why?
|
| Transfection | 1 | 2011 | 204 | 0.020 |
Why?
|
| Onium Compounds | 1 | 2010 | 2 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2010 | 41 | 0.020 |
Why?
|
| Trypanosoma cruzi | 1 | 2010 | 3 | 0.020 |
Why?
|
| Pyridines | 1 | 2010 | 79 | 0.020 |
Why?
|
| Nitrosation | 1 | 2010 | 4 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2010 | 84 | 0.020 |
Why?
|
| Membrane Microdomains | 1 | 2010 | 22 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2010 | 193 | 0.020 |
Why?
|
| Apoptosis | 1 | 2010 | 375 | 0.020 |
Why?
|
| Radiation, Ionizing | 1 | 2008 | 21 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 3898 | 0.020 |
Why?
|
| Biological Assay | 1 | 2008 | 18 | 0.020 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2007 | 19 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2007 | 37 | 0.020 |
Why?
|
| Antigens | 1 | 2007 | 34 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2007 | 43 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2007 | 59 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2015 | 3624 | 0.020 |
Why?
|
| Serum | 1 | 2006 | 14 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 215 | 0.020 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2006 | 10 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2008 | 897 | 0.010 |
Why?
|
| Synchrotrons | 1 | 2005 | 3 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2006 | 203 | 0.010 |
Why?
|
| Yeasts | 1 | 2003 | 7 | 0.010 |
Why?
|
| Transferrin-Binding Proteins | 1 | 2002 | 2 | 0.010 |
Why?
|
| Iron-Binding Proteins | 1 | 2002 | 4 | 0.010 |
Why?
|
| Zinc | 1 | 2002 | 29 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2002 | 149 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2002 | 251 | 0.010 |
Why?
|